FDA Boxed Warning Removal on Menopause Hormone Therapy: What Geriatricians Should Know

Sarina Hanfling^{1

2}, Sasha J Vereecken^{1

3}, Kate MacRae^{1

4}, Rachel Rubin^{1

4}

Affiliations

¹ Sexual Medicine Research Team, Bethesda, Maryland, USA.
² University of Maryland School of Medicine, Baltimore, Maryland, USA.
³ Division of Urology, Department of Surgery, University of Colorado, Aurora, Colorado, USA.
⁴ Georgetown University, Washington, D.C., USA.

Sarina Hanfling et al. J Am Geriatr Soc. 2025.

. 2025 Dec 12.

doi: 10.1111/jgs.70256. Online ahead of print.

Sarina Hanfling^{1

2}, Sasha J Vereecken^{1

3}, Kate MacRae^{1

4}, Rachel Rubin^{1

4}

¹ Sexual Medicine Research Team, Bethesda, Maryland, USA.
² University of Maryland School of Medicine, Baltimore, Maryland, USA.
³ Division of Urology, Department of Surgery, University of Colorado, Aurora, Colorado, USA.
⁴ Georgetown University, Washington, D.C., USA.

Abstract

A New Era for Menopause Hormone Therapy: Key Considerations for Geriatricians After FDA Boxed Warning Removal.

Keywords: genitourinary syndrome of menopause; menopause hormone therapy; vaginal estrogen.

1. K. K. Vesco, M. C. Leo, J. E. Bulkley, et al., “Improving Management of the Genitourinary Syndrome of Menopause: Evaluation of a Health System‐Based, Cluster‐Randomized Intervention,” American Journal of Obstetrics and Gynecology 224, no. 1 (2021): 62.e1–62.e13, https://doi.org/10.1016/j.ajog.2020.07.029.
1. S. Cox, R. Nasseri, R. S. Ru bin, and Y. Santiago‐Lastra, “Genitourinary Syndrome of Menopause,” Medical Clinics of North America 107, no. 2 (2023): 357–369, https://doi.org/10.1016/j.mcna.2022.10.017.
1. U.S. Food and Drug Administration, “FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women—July 17, 2025,” (2025), https://www.fda.gov/patients/fda‐expert‐panels/fda‐expert‐panel‐menopaus....
1. U.S. Food and Drug Administration, “FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies,” FDA, (2025), https://www.fda.gov/drugs/drug‐safety‐and‐availability/fda‐requests‐labe....
1. M. R. Kaufman, L. A. Ackerman, K. A. Amin, et al., “The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause,” Journal of Urology 214 (2025): 242–250, https://doi.org/10.1097/JU.0000000000004589.